VOLITIONRX LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update 2022-05-12 04:10
Volition Signs Exclusive $28 million License and Supply Agreement with Heska Corporation to Distribute Nu.Q® Vet Cancer Screening Test at the Point of Care 2022-03-29 20:00
Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia 2021-12-16 21:00
Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference 2021-11-04 20:33
VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update 2021-08-12 04:10
Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring 2021-07-22 20:00
VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update 2021-05-12 04:10
New Data Demonstrates Nu.Q® is Effective in Monitoring Treatment of Sepsis 2021-03-17 20:00
VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts 2021-02-02 20:45
VolitionRx Limited Opens its New Manufacturing Facility in Belgium 2021-01-25 21:45
Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S. 2020-12-01 21:45
VolitionRx Limited to Present COVID-19 Data at MEDICA 2020 2020-11-19 20:00
Volition Veterinary Presents Expert Report Ahead of First Product Launch 2020-11-10 21:00
VolitionRx Limited Releases Video of Virtual Capital Markets Day 2020 2020-10-21 20:00
Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference 2020-10-16 20:00
VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today 2018-08-01 19:00
1